Cookies

Like most websites The Ophthalmologist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

The IC-8™ IOL: Big Advantages Through Small Apertures

A global panel of experts discuss their experience with the IC-8 small aperture IOL including visual performance, patient selection, setting expectations and post-op management pearls


The AcuFocus IC-8 intraocular lens extends depth of focus by combining small aperture technology with a monofocal lens. This innovative design – incorporating an opaque mini ring with a central aperture – provides cataract patients with excellent quality of vision over a broad range of distances.

Subspecialties Cataract

Extended Range of Benefits

| Sponsored by AcuFocus

Explore the unique features of the IC-8 IOL.

Subspecialties Cataract

Extended Range of Patients

| Sponsored by AcuFocus

What kinds of patients are recommended an IC-8 lens by our expert panel?

Subspecialties Cataract

Extending Surgeon Expectations

| Sponsored by AcuFocus

Are refractive experts satisfied with their IC-8 IOL patients' outcomes?

Subspecialties Cataract

Extending Post-Operative Possibilities

| Sponsored by AcuFocus

What long-term implications does the IC-8 IOL have?

Subspecialties Cataract

Expert Consensus on the IC-8 IOL

| Sponsored by AcuFocus

Does the IC-8 IOL meet the experts' expectations?


Expert panel of ophthalmic surgeons

  • Boon Ham (Australia): General/pediatric ophthalmologist with interest in cataract/glaucoma surgery. He began implanting the IC-8 IOL in 2016.
  • Brendan Vote (Australia): General ophthalmologist with interests in cataract and retina; performs 750-1,000 cataract procedures per year. Has implanted the IC-8 IOL in ~80 patients since 2016.
  • Christopher Chan (Australia): General/refractive ophthalmologist treating primarily glaucoma, AMD, DR, dry eye and cataracts. Has implanted the IC-8 IOL in over 100 cataract patients including those presenting with irregular astigmatism, and significant nocturnal glare. He has also evaluated use of the IC-8 IOL in combination with other EDOF lenses – Symfony/Symfony™ toric.
  • Gerd Auffarth (Germany): Treats a complete spectrum of eye diseases; since 2015, has implanted the IC-8 IOL in a broad range of patients including cataract, refractive lens exchange, compromised corneas, and traumatic iris defects. He has also implanted the IC-8 lens in combination with the Oculentis MF 20™ lens.
  • Jacqueline Beltz (Australia): Focuses on cornea, cataract, and refractive patients; recently completed a comparison of the IC-8 IOL versus moderate monovision with monofocal IOLs in 40 patients.
  • Michael Shiu (Australia): Mainly treats cataract, glaucoma, and lens exchange patients; some AMD. Has implanted ~70 IC-8 IOLs, including bilateral IC-8 IOL implantation in irregular cornea patients, since 2018.
  • Sathish Srinivasan (UK): Primarily treats cornea, cataract, and refractive patients. Has implanted ~50 IC-8 IOLs since 2016, including in post-laser vision correction patients, postkeratotomy patients, refractive lens exchange and cataract patients.

Register to The Ophthalmologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine

Register